| 1 | Asthma, Exercise-Induced | 45.9% |
| 2 | Status Asthmaticus | 45.9% |
| 3 | Asthma, Aspirin-Induced | 33.5% |
| 4 | Aspergillosis, Allergic Bronchopulmonary | 22.7% |
| 5 | Bronchitis | 21.8% |
| 6 | Tracheobronchomegaly | 20.9% |
| 7 | Farmer's Lung | 20.8% |
| 8 | Bronchopneumonia | 19.7% |
| 9 | Bronchial Fistula | 17.8% |
| 10 | Bronchospasm | 16.7% |
| 11 | Bronchiectasis | 16.7% |
| 12 | Bronchial Hyperreactivity | 16.7% |
| 13 | Pneumoconiosis | 16% |
| 14 | Bronchial Neoplasms | 15.6% |
| 15 | Hay fever | 15.5% |
| 16 | Rhinitis, Allergic, Perennial | 15.5% |
| 17 | Bronchitis, Chronic | 15.2% |
| 18 | Bronchiolitis | 14.5% |
| 19 | Lung diseases | 14.3% |
| 20 | Pleural Diseases | 14.3% |
| 21 | Respiration Disorders | 14.3% |
| 22 | Thoracic Diseases | 14.3% |
| 23 | Tracheal Diseases | 14.3% |
| 24 | Pleurisy | 14% |
| 25 | Pneumonia | 14% |
| 26 | Lobar Pneumonia | 14% |
| 27 | Respiratory Distress Syndrome, Adult | 14% |
| 28 | Tracheitis | 14% |
| 29 | Pneumonitis | 14% |
| 30 | Pleuropneumonia | 13.6% |
| 31 | Granuloma, Laryngeal | 12.3% |
| 32 | Laryngeal Diseases | 12.2% |
| 33 | Nose Diseases | 12.2% |
| 34 | Laryngitis | 12% |
| 35 | Lung Diseases, Fungal | 12% |
| 36 | Rhinitis | 12% |
| 37 | Vocal Cord Dysfunction | 12% |
| 38 | anaphylaxis | 12% |
| 39 | Food Allergy | 12% |
| 40 | Anaphylactic shock | 12% |
| 41 | Respiratory Tract Infections | 11.9% |
| 42 | Respiratory Distress Syndrome, Newborn | 11.9% |
| 43 | Lung Abscess | 11.9% |
| 44 | Lung Neoplasms | 11.9% |
| 45 | Pleural Neoplasms | 11.9% |
| 46 | Tuberculosis, Pulmonary | 11.8% |
| 47 | Granuloma, Respiratory Tract | 11.8% |
| 48 | Respiratory Tract Fistula | 11.8% |
| 49 | Asbestosis | 11.7% |
| 50 | Berylliosis | 11.7% |
| 51 | Silicosis | 11.7% |
| 52 | Agricultural Workers' Diseases | 11.5% |
| 53 | Persian Gulf Syndrome | 11.5% |
| 54 | Choanal Atresia | 10.5% |
| 55 | Laryngocele | 10.5% |
| 56 | Tracheal Neoplasms | 10.3% |
| 57 | Pleural Effusion, Malignant | 10.1% |
| 58 | Urticaria | 10% |
| 59 | Sinusitis | 9.8% |
| 60 | Bronchiolitis Obliterans | 9.6% |
| 61 | Immune Complex Diseases | 9.4% |
| 62 | Latex allergy | 9.4% |
| 63 | Laryngeal neoplasm | 9.3% |
| 64 | Aspiration Pneumonia | 9.1% |
| 65 | Primary Ciliary Dyskinesia | 8.9% |
| 66 | Asthma | 8.6% |
| 67 | Kartagener Syndrome | 8.4% |
| 68 | Altitude Sickness | 8.4% |
| 69 | Atelectasis | 8.4% |
| 70 | Chylothorax | 8.4% |
| 71 | Hydropneumothorax | 8.4% |
| 72 | Hydrothorax | 8.4% |
| 73 | Pulmonary Hypertension | 8.4% |
| 74 | Pneumothorax | 8.4% |
| 75 | Pulmonary Alveolar Proteinosis | 8.4% |
| 76 | Pulmonary Edema | 8.4% |
| 77 | Pulmonary Fibrosis | 8.4% |
| 78 | Respiratory Insufficiency | 8.4% |
| 79 | Tracheal Stenosis | 8.4% |
| 80 | Hamman-Rich syndrome | 8.4% |
| 81 | Lung Diseases, Interstitial | 8.4% |
| 82 | Respiratory Depression | 8.4% |
| 83 | Lung Diseases, Obstructive | 8.4% |
| 84 | Respiratory Failure | 8.4% |
| 85 | Scimitar Syndrome | 8.3% |
| 86 | Acute Chest Syndrome | 8.1% |
| 87 | Hand-Arm Vibration Syndrome | 8.1% |
| 88 | Environmental Illness | 8.1% |
| 89 | Pneumonia, Viral | 8% |
| 90 | Dermatitis, Occupational | 7.9% |
| 91 | Idiopathic Pulmonary Fibrosis | 7.9% |
| 92 | Pneumonia, Bacterial | 7.9% |
| 93 | Laryngospasm | 7.8% |
| 94 | Hyaline Membrane Disease | 7.7% |
| 95 | Multiple Pulmonary Nodules | 7.7% |
| 96 | Meconium Aspiration Syndrome | 7.7% |
| 97 | Nose Neoplasms | 7.5% |
| 98 | Rhinoscleroma | 7.4% |
| 99 | Paranasal Sinus Neoplasms | 7.3% |
| 100 | Bronchial Diseases | 7.2% |
| 101 | Milk Allergy | 7.2% |
| 102 | Wheat Hypersensitivity | 7.2% |
| 103 | Sleep Disorders, Circadian Rhythm | 7% |
| 104 | Granuloma, Lethal Midline | 7% |
| 105 | Laryngeal Edema | 7% |
| 106 | Nose Deformities, Acquired | 7% |
| 107 | Lung Injury | 7% |
| 108 | Hepatopulmonary Syndrome | 7% |
| 109 | Respiratory Aspiration | 7% |
| 110 | Apnea | 6.9% |
| 111 | Cheyne-Stokes Respiration | 6.9% |
| 112 | Common Cold | 6.9% |
| 113 | Dyspnea | 6.9% |
| 114 | Hemothorax | 6.9% |
| 115 | Hyperventilation | 6.9% |
| 116 | Influenza | 6.9% |
| 117 | Mouth Breathing | 6.9% |
| 118 | Tachypnea | 6.9% |
| 119 | Catarrh | 6.9% |
| 120 | Pulmonary Embolism | 6.9% |
| 121 | Pulmonary Eosinophilia | 6.9% |
| 122 | Severe Acute Respiratory Syndrome | 6.9% |
| 123 | Eosinophilic Pneumonia | 6.9% |
| 124 | Laryngopharyngeal Reflux | 6.8% |
| 125 | Radiation Pneumonitis | 6.8% |
| 126 | Radiation Fibrosis | 6.8% |
| 127 | Hoarseness | 6.8% |
| 128 | Pneumonia, Lipid | 6.8% |
| 129 | Bronchomalacia | 6.7% |
| 130 | Kounis Syndrome | 6.6% |
| 131 | Dermatitis, Atopic | 6.6% |
| 132 | Autoimmune Diseases | 6.1% |
| 133 | Immunologic Deficiency Syndromes | 6.1% |
| 134 | Immunoproliferative Disorders | 6.1% |
| 135 | Immune reconstitution syndrome | 6.1% |
| 136 | Immune Reconstitution Inflammatory Syndrome | 6.1% |
| 137 | Pharyngitis | 6% |
| 138 | Laryngostenosis | 6% |
| 139 | Nasal Polyps | 6% |
| 140 | Respiratory Hypersensitivity | 5.9% |
| 141 | Hemoptysis | 5.9% |
| 142 | Pertussis | 5.9% |
| 143 | Airway Obstruction | 5.5% |
| 144 | Choking | 5.5% |
| 145 | Epiglottitis | 5.5% |
| 146 | Chronic Obstructive Airway Disease | 5.5% |
| 147 | Mediastinitis | 5.5% |
| 148 | Middle Lobe Syndrome | 5.5% |
| 149 | Acute Lung Injury | 5.5% |
| 150 | Maxillary Sinus Neoplasms | 5.4% |
| 151 | Blastomycosis | 5.4% |
| 152 | Anti-Glomerular Basement Membrane Disease | 5.3% |
| 153 | Cystic Fibrosis | 5.3% |
| 154 | Voice Disorders | 5.2% |
| 155 | Voice Disturbance | 5.2% |
| 156 | Epistaxis | 5.2% |
| 157 | Transfusion-Related Acute Lung Injury | 5.1% |
| 158 | Angioedema | 5.1% |
| 159 | Transfusion Reaction | 5.1% |
| 160 | Hypotensive Transfusion Reaction | 5.1% |
| 161 | Granulomatosis with polyangiitis | 5.1% |
| 162 | Serum Sickness | 5% |
| 163 | Laryngomalacia | 4.6% |
| 164 | Mediastinal Cyst | 4.6% |
| 165 | Pericardial Cyst | 4.6% |
| 166 | Persistent Fetal Circulation Syndrome | 4.6% |
| 167 | Thymic Cyst | 4.6% |
| 168 | Vocal Cord Paralysis | 4.6% |
| 169 | Croup | 4.6% |
| 170 | Histiocytosis, Langerhans-Cell | 4.6% |
| 171 | Mediastinal Emphysema | 4.6% |
| 172 | Rhinitis, Vasomotor | 4.6% |
| 173 | Pulmonary Aspergillosis | 4.6% |
| 174 | Bronchopulmonary Aspergillosis | 4.6% |
| 175 | Hypoventilation | 4.6% |
| 176 | Acidosis, Respiratory | 4.5% |
| 177 | Alkalosis, Respiratory | 4.5% |
| 178 | Sarcoidosis, Pulmonary | 4.5% |
| 179 | Sleep Apnea Syndromes | 4.5% |
| 180 | Pulmonary Infarction | 4.5% |
| 181 | Sick Building Syndrome | 4.3% |
| 182 | Multiple Chemical Sensitivity | 4.3% |
| 183 | Vasculitis, Leukocytoclastic, Cutaneous | 4.3% |
| 184 | Glomerulonephritis, Membranoproliferative | 4.2% |
| 185 | Pulmonary Emphysema | 4.1% |
| 186 | Tonsillitis | 3.9% |
| 187 | Dyspnea, Paroxysmal | 3.9% |
| 188 | Respiratory Paralysis | 3.9% |
| 189 | Mastocytosis | 3.7% |
| 190 | Drug Eruptions | 3.6% |
| 191 | Dermatitis, Allergic Contact | 3.6% |
| 192 | Asthma, Occupational | 3.5% |
| 193 | Bronchopulmonary Dysplasia | 3.4% |
| 194 | Aphonia | 3.4% |
| 195 | Retropharyngeal Abscess | 3.4% |
| 196 | Dysphonia | 3.4% |
| 197 | Sleep Apnea, Obstructive | 3.4% |
| 198 | Sleep Apnea, Central | 3.4% |
| 199 | Tracheomalacia | 3.4% |
| 200 | Thrombocytopenic purpura | 3.2% |
| 201 | Antiphospholipid Syndrome | 3.1% |
| 202 | Autoimmune Lymphoproliferative Syndrome | 3% |
| 203 | Nasopharyngitis | 3% |
| 204 | Angioedemas, Hereditary | 3% |
| 205 | Invasive Pulmonary Aspergillosis | 2.9% |
| 206 | Autoimmune thrombocytopenia | 2.7% |
| 207 | Immune thrombocytopenic purpura | 2.7% |
| 208 | Lupus Erythematosus, Systemic | 2.6% |
| 209 | Lymphoproliferative Disorders | 2.6% |
| 210 | Overlap syndrome | 2.6% |
| 211 | Addison Disease | 2.6% |
| 212 | Paraproteinemias | 2.6% |
| 213 | Pemphigus | 2.6% |
| 214 | Autoimmune thyroiditis | 2.6% |
| 215 | Primary Adrenal Insufficiency | 2.6% |
| 216 | Lymphopenia | 2.6% |
| 217 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.6% |
| 218 | Autoimmune hepatitis | 2.6% |
| 219 | Mastocytosis, Systemic | 2.5% |
| 220 | Peritonsillar Abscess | 2.5% |
| 221 | Hereditary Angioedema Type III | 2.5% |
| 222 | Hereditary Angioedema Types I and II | 2.5% |
| 223 | Eosinophilic Granuloma | 2.3% |
| 224 | Hypergammaglobulinemia | 2.2% |
| 225 | Latent Autoimmune Diabetes in Adults | 2.2% |
| 226 | Agammaglobulinemia | 2.2% |
| 227 | Dermatitis Herpetiformis | 2.2% |
| 228 | HIV Infections | 2.2% |
| 229 | Acute Generalized Exanthematous Pustulosis | 2.2% |
| 230 | Primary amyloidosis | 2.1% |
| 231 | Monoclonal Gammopathy of Undetermined Significance | 2.1% |
| 232 | Rheumatoid Arthritis | 1.9% |
| 233 | Juvenile arthritis | 1.9% |
| 234 | Graves Disease | 1.9% |
| 235 | Erythema Nodosum | 1.9% |
| 236 | Dermatitis, Photoallergic | 1.9% |
| 237 | Multiple Myeloma | 1.7% |
| 238 | Kernicterus | 1.5% |
| 239 | Toxic Epidermal Necrolysis | 1.5% |
| 240 | Stevens-Johnson Syndrome | 1.5% |
| 241 | Plasmacytoma | 1.4% |
| 242 | Tumor Lysis Syndrome | 1.4% |
| 243 | HTLV-I Infections | 1.4% |
| 244 | Job Syndrome | 1.4% |
| 245 | Ataxia Telangiectasia | 1.4% |
| 246 | Hydrops Fetalis | 1.4% |
| 247 | Lymphoma | 1.2% |
| 248 | Myasthenia Gravis | 1.2% |
| 249 | Uveomeningoencephalitic Syndrome | 1.2% |
| 250 | Chronic granulomatous disease | 1.2% |
| 251 | Heavy Chain Disease | 1.2% |
| 252 | HIV Seropositivity | 1.2% |
| 253 | Sezary Syndrome | 1.2% |
| 254 | Stiff-Person Syndrome | 1.1% |
| 255 | Polyradiculoneuropathy | 1.1% |
| 256 | Polyradiculoneuritis | 1.1% |
| 257 | Acquired Immunodeficiency Syndrome | 1.1% |
| 258 | AIDS related complex | 1.1% |
| 259 | Infectious Mononucleosis | 1.1% |
| 260 | Cryoglobulinemia | 1.1% |
| 261 | Felty Syndrome | 1.1% |
| 262 | POEMS Syndrome | 1.1% |
| 263 | Lupus Nephritis | 1% |
| 264 | Schnitzler Syndrome | 1% |
| 265 | Myasthenia Gravis, Autoimmune, Experimental | 1% |
| 266 | AIDS-Related Opportunistic Infections | 1% |
| 267 | Vasculitis, Central Nervous System | 0.9% |
| 268 | HIV Wasting Syndrome | 0.9% |
| 269 | Rheumatoid Vasculitis | 0.9% |
| 270 | AIDS Dementia Complex | 0.9% |
| 271 | AIDS-Associated Nephropathy | 0.9% |
| 272 | Lupus Vasculitis, Central Nervous System | 0.9% |
| 273 | Lambert-Eaton Myasthenic Syndrome | 0.8% |
| 274 | Waldenstrom Macroglobulinemia | 0.8% |
| 275 | Wiskott-Aldrich Syndrome | 0.8% |
| 276 | Sicca Syndrome | 0.8% |
| 277 | Sjogren's Syndrome | 0.8% |
| 278 | HIV-Associated Lipodystrophy Syndrome | 0.8% |
| 279 | Multiple Sclerosis | 0.7% |
| 280 | Hodgkin Disease | 0.7% |
| 281 | Leukemia, Plasma Cell | 0.7% |
| 282 | Lymphoma, Non-Hodgkin | 0.7% |
| 283 | Leukemia, T-Cell | 0.7% |
| 284 | Leukemia, B-Cell | 0.7% |
| 285 | Neuromyelitis Optica | 0.7% |
| 286 | Leukoencephalitis, Acute Hemorrhagic | 0.7% |
| 287 | Composite Lymphoma | 0.6% |
| 288 | Encephalomyelitis, Acute Disseminated | 0.6% |
| 289 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.6% |
| 290 | Neuritis, Autoimmune, Experimental | 0.6% |
| 291 | Lymphangioleiomyomatosis | 0.6% |
| 292 | Guillain-Barre Syndrome | 0.6% |
| 293 | Multiple Sclerosis, Chronic Progressive | 0.5% |
| 294 | Multiple Sclerosis, Relapsing-Remitting | 0.5% |
| 295 | Lymphoma, Follicular | 0.5% |
| 296 | T-Cell Lymphoma | 0.5% |
| 297 | Mantle cell lymphoma | 0.5% |
| 298 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.5% |
| 299 | Leukemia, Large Granular Lymphocytic | 0.5% |
| 300 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.5% |
| 301 | Giant Cell Arteritis | 0.5% |
| 302 | Temporal Arteritis | 0.5% |
| 303 | Myelitis, Transverse | 0.4% |
| 304 | Lymphoma, T-Cell, Cutaneous | 0.4% |
| 305 | Lymphoma, AIDS-Related | 0.4% |
| 306 | Enteropathy-Associated T-Cell Lymphoma | 0.4% |
| 307 | Primary Effusion Lymphoma | 0.4% |
| 308 | Lymphomatoid Granulomatosis | 0.3% |
| 309 | Mycosis Fungoides | 0.3% |
| 310 | Lymphomatoid Papulosis | 0.3% |
| 311 | Plasmablastic lymphoma | 0.3% |
| 312 | Miller Fisher Syndrome | 0.3% |
| 313 | Burkitt Lymphoma | 0.3% |